简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-01-23 15:43 LTIMindtree Renews its Strategic Alliance with the Association of American Medical Colleges (AAMC)
2025-01-23 14:07 IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership
2025-01-23 10:56 Novotech Releases Comprehensive Report on Oncolytic Virus Therapy
2025-01-22 10:26 New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
2025-01-21 12:03 SBC Medical Launches Translation App Specialized Medical Aesthetics and Strengthens "Inbound-Focused Clinics" Initiative
2025-01-17 10:06 Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials
2025-01-17 09:36 SINOVAC Issues Statement Regarding Privy Council Judgment
2025-01-15 11:12 Mesmerise to collaborate with Mayo Clinic to Transform Medical Education and Healthcare Workforce Training
2025-01-14 14:03 Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss
2025-01-14 11:51 Zepp Health to Showcase Groundbreaking Innovations at CES Pepcom & ShowStoppers Media Events
2025-01-14 11:47 Caidya Announces $165 Million Strategic Growth Investment From Rubicon Founders
2025-01-10 10:17 BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
2025-01-10 10:14 Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
2025-01-08 12:41 Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors
2025-01-08 10:51 Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
2025-01-07 09:30 Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
2024-12-27 15:08 Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
2024-12-26 09:07 Kirin’s Electric Salt Spoon Shines At CES Innovation Awards 2025, Earning First-Ever Wins In Digital Health and Accessibility & Age Tech!
2024-12-24 10:35 BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
2024-12-24 10:11 Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases

Business Wire Weibo

Press Releases

Latest Releases